$10,000 invested in these ASX healthcare shares 5 years ago is now worth…

These healthcare stocks have brought big returns for investors 

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX healthcare shares are often regarded as less represented in the Australian economy. 

While this is true compared to financials (big banks) and resources (mining giants), there are healthcare shares have brought big returns for investors in recent times. 

Projecting which ones will produce these big returns is another challenge. 

In the last 5 years, the S&P/ASX 200 Health Care (ASX:XHJ) index has grown just 2%. 

Here are two of the outliers.

Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital

Image source: Getty Images

Pro Medicus Ltd (ASX: PME)

Pro Medicus Ltd (ASX: PME) is a provider of medical imaging technology globally. 

The company is recognised as a leading supplier of radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualisation solutions for medical practices and hospitals.

Its share price lay dormant for many years, before gaining some momentum in the late 2010s. 

Five years ago its share price sat at roughly $25.

Since then, it has seen rapid growth to become one of the largest healthcare stocks by market capitalisation in Australia. 

For holders of this stock, it's been the gift that keeps on giving. 

Pro Medicus was the second best performing ASX 200 healthcare shares last financial year, with 99% share price growth.

At the time of writing, its share price sits at $314.20. 

A $10,000 investment in Pro Medicus five years ago would be worth approximately $124,290 today – a 1,143% return.

This is before taking into consideration any dividends or reinvented earnings. 

Can the bull run continue?

Its success has come on the back of high margins, zero debt, a sticky client base, and strong earnings growth.

However, based on reporting from The Motley Fool's Brownwyn Allen, experts believe its share price could be overvalued right now. 

Sigma Healthcare Ltd (ASX: SIG)

Sigma Healthcare engages in the manufacture and distribution of pharmaceutical products through pharmacy, grocery channels, and private label.

The share price for this ASX healthcare stock remained flat for much of the last five years, before taking off in 2024. 

In total, it is up 367.19% over the past 5 years. 

This included 130% in FY25 alone, making it the best performing healthcare stock. 

A $10,000 investment in Sigma Healthcare five years ago would be worth approximately $46,718.75 today – a 367% return.

Is it still a buy?

Yesterday my colleague Bernd Struben reported that one broker in particular doesn't recommend adding more shares to your portfolio today.

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Here's why I'd buy and hold CSL and Cochlear shares for 10 years

The market is focused on the problems, but I think the decade-long opportunity still looks attractive.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Here's what brokers tip for CSL shares over the next 12 months

Can CSL shares keep climbing higher?

Read more »

A businessman holds his hand to his wide-open yawning mouth as he closes his eyes and makes a funny face while he gives a wholehearted yawn.
Broker Notes

How much could ResMed shares rise according to Morgans?

Current share price weakness could be an opportunity.

Read more »

Doctor checking patient's spine x-ray image.
Healthcare Shares

This healthcare stock just jumped 15% and experts are tipping a further 80% rise 

Momentum is building for this exciting stock.

Read more »

A smiling young couple sit with a finance professional at a computer, looking at the screen.
Healthcare Shares

3 reasons why the ASX share owner of Chemist Warehouse is a buy

I think Chemist Warehouse is a great business for a few reasons.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Healthcare Shares

How have CSL shares performed over 10 years?

Was it a good idea to buy the biotech giant's shares in 2016? Here are the returns.

Read more »

Young girl shows hearing aid while smiling.
Healthcare Shares

Cochlear shares have bounced 16%. Should you buy, hold, or sell now?

Analysts reveal whether Cochlear's recovery still has room to run.

Read more »

A doctor looks unsure.
Healthcare Shares

Down 9%: Is the rebound over for Telix shares?

Find out what brokers tip next for the ASX biopharmaceutical company.

Read more »